Please login to the form below

Not currently logged in

Excellence in Patient Education and Support

Sponsored by

Back to Results


On Path Patient Support Programme - UK

by Amgen
with support from Atlantis Healthcare UK

Summary of work

PCSK9-inhibitors (PCSK9i) are a new class of lipid-lowering biologics for hypercholesterolaemia patients uncontrolled on statins and at risk of cardiovascular events.

Adherence was likely to be a key challenge for this new class of drugs, given their fortnightly subcutaneous administration in this asymptomatic indication, versus the once-daily oral regimen for statins.

Amgen wished to launch a patient support programme (PSP) for its new PCSK9i, Repatha®. Its aim - to deliver value beyond the drug and support optimal adherence; critical in supporting successful commercialisation of Repatha in the UK.

On Path is a unique multichannel PSP based on health psychology principles developed by Atlantis Healthcare for Amgen. It supports successful treatment initiation and promotes persistence. The programme provides tools to upskill patients to better self-manage their condition. Patients set health-related goals and are supported by a personal nurse coach to support proactive self-management.

On Path has had a positive impact on treatment persistence, confidence in treatment administration and reduction in injection concerns, exemplifying patients’ positive first experience with Repatha and successful initiation. Patients have also indicated a high degree of satisfaction with the programme experience overall. The service has been successfully adopted by the NHS and integrated into the patient pathway.

Judges' comments

This impressive entry is a strong behavioural change programme that was coupled with real-life involvement and insightful clinical feedback. The team applied smart objectives to its care pathway and delivered strong results, which was refreshing to see. This is a consistently robust programme and a worthy winner.

Highly commended

MyAsthma - by GSK
with support from The EarthWorks


Empowering Your Future - Living with Squamous Cell Lung Cancer - by Eli Lilly and Company
with support from Complete HealthVizion

Pfizer Liaison - Partnering to Provide Support and Improve Cancer Patients’ Lives - by Pfizer Canada
with support from Lemieux Bédard Communications

Skin-telligence - by Thornton & Ross
with support from Pegasus

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022